PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Lariboisière Fernand Widal Hospital, AP-HP, University of Paris.\', \'Department of Internal Medicine and Infectious Diseases, Diaconesses Croix-Saint Simon Hospital.\', \'Reproductive Medicine Unit, Diaconesses Croix-Saint Simon Hospital.\', \'Department of Internal Medicine, Rothschild Hospital Foundation.\', \'Biostatistics and Clinical Trial Unit, Lariboisière Fernand Widal Hospital, AP-HP.\', \'Intensive Care Unit, Rothschild Hospital Foundation.\', \'Intensive Care Unit, Diaconesses Croix-Saint Simon Hospital.\', \'Anesthesiology Department, Diaconesses Croix-Saint Simon Hospital.\', \'Emergency Department, Diaconesses Croix-Saint Simon Hospital, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000026023
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34032722
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all